8-KThe WireStrategic
Results of Operations · Reg FD Disclosure
Filed May 7, 2026 · 1mo ago · Accession 0001193125-26-211843
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Xenon Pharmaceuticals Inc.
- Ticker
- XENE
- CIK
- 1582313
- Form type
- 8-K
- Filing date
- May 7, 2026
- Report date
- May 7, 2026
- Document
- xene-20260507.htm
- Size
- 371 KB